Trial results announced this month showed that patients given the immunotherapy medicine nivolumab alongside chemotherapy prior to surgery were more likely to live longer, compared to those given chemo alone. Sufferers ...
from Google Alert - health https://ift.tt/qzwLdbY
via IFTTT
0 comments:
Post a Comment